MedTrace Logo

Investigation of Factors Causing Knee Hyperextension During Walking in Chronic Stroke Patients

NCT05513781 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2024-02-28

No results posted yet for this study

Summary

In this study, it is aimed to examine the factors that cause knee hyperextension in chronic stroke patients. Although the presence of weakness or spasticity in the quadriceps muscle, weakness or spasticity in the plantar flexors, and weakness of the dorsiflexors, hamstrings and gastrocnemius muscle are shown in the literature as the cause of hyperextension of the affected knee in hemiplegic patients, there is a comprehensive study that shows the effect of both muscle strength and spasticity in the lower extremity muscles. there are no studies.

The hypotheses of the study are:

Hypothesis 1:

H0: There is no relationship between knee hyperextension in the stance phase of gait and lower extremity muscle strength in stroke patients.

H1: There is a relationship between knee hyperextension in the stance phase of gait and lower extremity muscle strength in stroke patients.

Hypothesis 2; H0: There is no relationship between knee hyperextension in the stance phase of gait and lower extremity spasticity in stroke patients.

H1: There is a relationship between knee hyperextension in the stance phase of gait and lower extremity spasticity in stroke patients.

Hypothesis 3; H0: There is no relationship between knee hyperextension and electromyographic muscle activations in chronic stroke patients.

H1: There is a relationship between knee hyperextension and electromyographic muscle activations in chronic stroke patients.

Conditions

Sponsors & Collaborators

  • Atılım University

    collaborator OTHER

  • Hacettepe University

    lead OTHER

Principal Investigators

  • Kadriye Armutlu, Prof. Dr. · Hacettepe University

  • Süleyman Korkusuz, MSc · Hacettepe University

  • Sibel Kibar, Assoc. Prof. · Atılım University

  • Serdar Arıtan, Asst.Prof · Hacettepe University

  • Nihat Özgören, MSc · Hacettepe University

  • Ali Naim Ceren, Msc · Hacettepe University

  • Büşra Seçkinoğulları, MSc · Hacettepe University

  • Ayla Fil Balkan, Assoc.Prof · Hacettepe University

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-20
Primary Completion
2023-10-11
Completion
2023-11-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05513781 on ClinicalTrials.gov